1 “... with estrogen receptor-positive (ER+) and lymph node-negative (LN) early invasive breast cancer, the use of ODX...”

2 “... with estrogen receptor-positive (ER+) and lymph node-negative (LN) early invasive breast cancer, the use of ODX...”

3 “... and evidence-based guidelines regarding the effectiveness and use of Trendelenburg patient positioning during a...”

4

5

6 Subjects: “...Continuous Positive Airway Pressure...”

7 Subjects: “...Continuous Positive Airway Pressure...”

8 Subjects: “...Continuous Positive Airway Pressure...”

9 Subjects: “...Positive-Pressure Respiration...”

10 Subjects: “...Continuous Positive Airway Pressure...”

11 Subjects: “...Continuous Positive Airway Pressure / methods...”

12 “...For patients with estrogen receptor-positive (ER+) and lymph node-negative (LN+) early stage breast...”

13 “...For patients with estrogen receptor-positive (ER+) and lymph node-negative (LN+) early stage breast...”

14 “..., autoantibody-positive SLE. This submission relates to belimumab subcutaneous (SC) injection, 200 mg/mL weekly...”

15 “... activity in adult patients with active, autoantibody-positive systemic lupus erythematosus...”

16 “... activity in adult patients with active, autoantibody-positive systemic lupus erythematosus...”

17 “..., autoantibody-positive SLE. This submission relates to belimumab subcutaneous (SC) injection, 200 mg/mL weekly...”

18 “... as unnecessary anticoagulation due to either false-positives or long wait times to receive a final diagnosis...”

19 “... as unnecessary anticoagulation due to either false-positives or long wait times to receive a final diagnosis...”

20 “... for missed diagnoses, as well as unnecessary anticoagulation due to either false-positives or long wait times...”